Advanced Technologies & Treatments for Diabetes (ATTD)

What Advanced Technologies & Treatments for Diabetes (ATTD) does

ATTD (Advanced Technologies & Treatments for Diabetes) is a Geneva-headquartered medical conference and continuing-education organization founded in 2008, focused on diabetes technology and therapeutics. It runs an annual international conference (ATTD), a regional Asian conference series (ATTD-ASIA launched in 2024), and a digital education platform (UNLOK launched in 2023), and serves endocrinologists, diabetologists, pediatricians, researchers, medical device and pharmaceutical companies, startups, investors, regulators, and people living with diabetes across more than 100 countries. The organization is managed and operated by Kenes Group, a professional conference organizer headquartered in Geneva, and maintains a small internal team of 1-10 employees.

The product portfolio comprises the flagship ATTD global conference, ATTD-ASIA regional meetings, the UNLOK Education Portal offering accredited CME courses, webinars, and microlearning, the Diabetes Technology & Therapeutics (DTT) peer-reviewed journal published in partnership with Mary Ann Liebert and hosted on Sage Journals, the annual ATTD Yearbook summarizing key research, the Tech Fair startup exhibition zone, and the ATTD Ignite pitch and thought-leadership forum. The underlying technology stack includes a mobile conference app, an LMS-based digital education portal, AI-generated podcast tooling for the Conference Catch-Up series, and content management for abstracts and e-Posters; medical education content is co-developed with GEMS using adult-learning principles.

ATTD's revenue model is built on five streams: conference registration fees from healthcare professional delegates (with in-person and virtual options), exhibition and sponsorship packages sold to pharmaceutical and medical device companies, Tech Fair participation fees partially offset by a EUR 2,500 startup grant, industry educational grants underwriting UNLOK content, and special subscription arrangements for the DTT journal. Go-to-market is event-driven and community-led, relying on the scientific reputation of the program and journal, multi-channel digital marketing, and the Kenes Group operational backbone, while the customer base spans enterprise sponsors, mid-market startups, and individual clinician subscribers to UNLOK.

Name

Advanced Technologies & Treatments for Diabetes (ATTD)

Legal name

Advanced Technologies & Treatments for Diabetes (ATTD)

Website

https://attd.kenes.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

ATTD is a Geneva-based medical conference and continuing-education organization that runs the annual ATTD global conference, the ATTD-ASIA regional conference, and the UNLOK digital education portal, serving endocrinologists, researchers, medtech companies, startups, and investors in the diabetes technology field.

Ownership category

akta.pro rank

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Technology or R&D, Others

Revenue model

1. Conference Registration Fees: Revenue generated from healthcare professional delegates attending ATTD annual conferences and ATTD-ASIA regional meetings. Events offer in-person and virtual participation options.
2. Exhibition and Sponsorship: Companies showcase breakthrough technologies, meet decision-makers, and create new partnerships through exhibition booths, sponsorships, and promotional opportunities at ATTD events.
3. Tech Fair Participation: Startup companies and emerging companies pay to participate in the Tech Fair exhibition area to gain visibility with investors and industry leaders. ATTD provides a EUR 2,500 grant to qualifying startups.
4. UNLOK Education Partnerships: Educational grants from industry partners to support high-quality medical education through the UNLOK platform for certified and accredited medical learning opportunities.
5. DTT Journal Subscriptions: Special subscription rates for ATTD attendees on the official journal Diabetes Technology & Therapeutics, published by Mary Ann Liebert, Inc.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels12 records

Core offering

ATTD operates as a global medical conference and education platform dedicated to diabetes technology and treatments. It runs the annual international ATTD conference, regional ATTD-ASIA meetings, the UNLOK Education Portal for accredited online learning, the peer-reviewed Diabetes Technology & Therapeutics (DTT) Journal, the annual ATTD Yearbook, and startup-focused initiatives (Tech Fair, ATTD Ignite). The platform convenes clinicians, researchers, industry leaders, startups, and patients to advance early detection, treatments, and emerging technologies in diabetes care.

Product overview

ATTD is a global conference and education platform organized around an annual international conference (ATTD) and regional Asian conference (ATTD-ASIA), serving as the premier venue for diabetes professionals. The platform operates as a multi-product ecosystem comprising: the core ATTD conferences bringing together clinicians, researchers, and industry; the ATTD on UNLOK Education Portal offering online accredited courses, webinars, and podcasts; the Diabetes Technology & Therapeutics (DTT) Journal as its official peer-reviewed publication; the ATTD Yearbook summarizing key articles; and the Tech Fair and ATTD Ignite initiatives supporting startup innovation in diabetes technology. GEMS (Global Education of Medicine and Science) collaborates on independent medical education development.

Differentiator

Problem solved

Functional benefit

Brands

• Tech Fair: International Fair of New Technologies in Diabetes - a specific zone within the ATTD exhibition area designed for startups to gain exposure and connect with KOLs by showcasing innovative solutions.
• ATTD Ignite
• ATTD Yearbook
• Diabetes Technology & Therapeutics (DTT) Journal

Products and services

• ATTD Global Conferences Annual international conferences (ATTD) bringing together clinicians, researchers, healthcare providers, industry leaders, and innovators to exchange insights on diabetes technology, treatments, closed-loop systems, artificial pancreas, glucose sensors, and emerging insulin formulations.
• ATTD-ASIA Regional Conferences Regional Asian conferences (e.g., ATTD-ASIA 2025 in Singapore, ATTD-ASIA 2026 in Kyoto) attracting 800+ delegates from 50+ countries, focused on expanding reach across APAC.
• ATTD on UNLOK Education Portal Online digital education platform offering live webinars, accredited CME courses, microlearning, on-demand conference recordings, podcasts, expert content, and interactive forums for healthcare professionals specializing in diabetes.
• Diabetes Technology & Therapeutics (DTT) Journal Official peer-reviewed journal of ATTD providing comprehensive coverage of new devices, drugs, drug delivery systems, and software for managing patients with diabetes, with special subscription rates for ATTD attendees.
• ATTD Yearbook Annual publication featuring a selection of the most relevant published data in diabetes technology, with critical reviews of the most important articles selected by key opinion leaders.
• ATTD Tech Fair International fair zone within ATTD exhibitions designed for startups to showcase innovative diabetes technology solutions, gain exposure to investors and Key Opinion Leaders (KOLs), and accelerate development, with EUR 2,500 grants to qualifying startups.
• ATTD Ignite Half-day thought leadership and startup inspiration event featuring groundbreaking keynotes, Shark Tank-style pitch sessions (Tech Tank), and networking opportunities for clinicians, entrepreneurs, researchers, investors, and industry leaders.

Quantifiable outcome

• 5,000+ healthcare professionals attend ATTD annual conferences from 100+ countries
• +2 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• GEMS - Global Education of Medicine and SciencecoreStrategic or Co-development PartnerGEMS collaborates with ATTD to develop and deliver high-quality medical education activities targeting healthcare professionals internationally. GEMS provides adult learning principles and needs-based educational content development, supporting ATTD's mission to advance physician competencies and improve patient care.
• Kenes GroupcoreImplementation/ SI/ Consulting PartnerKenes Group serves as the professional conference management company for ATTD, handling event organization, venue management, logistics, registration services, and digital platform operations including the ATTD website and conference management systems.
• Mary Ann Liebert, Inc.coreStrategic or Co-development PartnerMary Ann Liebert, Inc. is the publisher of the ATTD official journal Diabetes Technology & Therapeutics and the ATTD Yearbook, providing peer-reviewed publication services and conference abstract management.
• UNLOK Education PlatformcoreTechnology or IntegrationUNLOK is the digital education platform partner providing the technology infrastructure for ATTD's online education portal, including course management, webinar hosting, CME credit tracking, and mobile learning capabilities.
• Sage JournalscoreTechnology or IntegrationSage Journals hosts the Diabetes Technology & Therapeutics journal and conference abstracts on their publishing platform, providing online access, subscription management, and digital content delivery.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Emerging players

• Cardiometabolic Health Congress (CMHC): Operates the annual CMHC conference covering cardiometabolic disease, including substantial diabetes content. Comparable as a CME-accredited medical congress targeting a related chronic-disease clinician audience with sponsorship-driven revenue.
• JDRF (Breakthrough T1D): Largest global funder of type 1 diabetes research that operates its own scientific summits, researcher networks, and industry partnerships. Comparable in convening clinicians, researchers, and industry around diabetes technology innovation, with overlapping speakers and audience.

Direct peers

• European Association for the Study of Diabetes (EASD): Runs the EASD Annual Meeting, the leading European diabetes research congress, and publishes Diabetologia. Directly comparable in operating a flagship annual conference, peer-reviewed journal, and educational programs for endocrinologists and diabetologists.
• International Diabetes Federation (IDF): Global umbrella organization for diabetes that operates the IDF World Diabetes Congress and Diabetes Atlas. Directly comparable in convening a global, multi-stakeholder diabetes audience through large-scale events and educational initiatives.
• American Diabetes Association (ADA): The largest diabetes-focused professional organization globally and the operator of the ADA Scientific Sessions, the premier annual diabetes research conference. Directly comparable as a medical association running an annual scientific congress, peer-reviewed journals, and continuing education for the same clinician audience.
• International Society for Pediatric and Adolescent Diabetes (ISPAD): Operates the ISPAD Annual Conference focused on pediatric and adolescent diabetes. Directly comparable as a specialty diabetes medical society running an annual congress and scientific programming for a clinically overlapping audience.

Broad incumbents

• Heart Rhythm Society (HRS): Operates Heart Rhythm, the leading electrophysiology congress, alongside the Heart Rhythm O2 journal and extensive CME programs. Comparable as a medical specialty society running a global annual conference, peer-reviewed journal, and digital education platform on a similar operating model.
• American Association of Clinical Endocrinology (AACE): Operates the AACE Annual Meeting and the Endocrine Practice journal. Comparable as a clinical endocrinology society that runs a major annual conference and CME programs serving many of the same endocrinologists and diabetes specialists that attend ATTD.
• The Endocrine Society: Operates ENDO, a major endocrinology congress with significant diabetes content, alongside the Journal of the Endocrine Society. Comparable as a medical society running a large annual conference, peer-reviewed journal, and CME programs that overlap substantially with ATTD's clinician audience.

Regional players

• Diabetes UK: UK-based diabetes charity that runs the Diabetes UK Professional Conference. Comparable in operating an annual scientific conference, peer-reviewed content, and education programs for clinicians, though focused primarily on the UK market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/ATTDconf
• YouTubeyoutube.com/channel/UCOO8mdqFBNccgJotjIqpU9A
• Facebookfacebook.com/ATTDConf/?ref=hl
• LinkedInlinkedin.com/company/attddiabetes
• Instagraminstagram.com/attdconference

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Technologies & Treatments for Diabetes (ATTD)